Chengzhi Co Ltd Class A 000990
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 8.95
- Day Range
- CNY 8.53–8.90
- 52-Week Range
- CNY 5.96–8.95
- Bid/Ask
- CNY 8.56 / CNY 8.57
- Market Cap
- CNY 10.41 Bil
- Volume/Avg
- 90.9 Mil / 19.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 26.77
- Price/Sales
- 0.92
- Dividend Yield (Trailing)
- 1.35%
- Dividend Yield (Forward)
- 1.35%
- Total Yield
- 1.23%
Company Profile
Chengzhi Co Ltd, formerly Chengzhi Shareholding Co Ltd is a China-based company engaged in the businesses of clean energy, functional materials and medical care and health.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 4,195
- Website
- http://www.chengzhi.com.cn
Comparables
Valuation
|
Metric
|
000990
|
000403
|
688192
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.77 | 32.95 | — |
Price/Book Value | 0.61 | 2.80 | 24.33 |
Price/Sales | 0.92 | 8.41 | 96.76 |
Price/Cash Flow | 4.94 | 40.45 | — |
Price/Earnings
000990
000403
688192
Financial Strength
|
Metric
|
000990
|
000403
|
688192
|
|---|---|---|---|
Quick Ratio | — | 2.66 | 1.59 |
Current Ratio | — | 4.01 | 1.80 |
Interest Coverage | — | 88.68 | −100.52 |
Quick Ratio
000990
000403
688192
Profitability
|
Metric
|
000990
|
000403
|
688192
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.64% | −66.38% |
Return on Equity (Normalized) | — | 8.84% | −99.78% |
Return on Invested Capital (Normalized) | — | 7.59% | −78.11% |
Return on Assets
000990
000403
688192
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qkszzfthwc | Jbdn | $567.0 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Jtvdpcpx | Hhspcrd | $109.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Jwlfdrd | Gfglyv | $105.3 Bil | |
MRNA
| Moderna Inc | Yqyhbkkk | Gskf | $47.0 Bil | |
ARGX
| argenx SE ADR | Bhsymsjm | Wpkvt | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Hmfngbm | Ljx | $22.1 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Jgfxfhxx | Zrfjtjy | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rpyyfgd | Qtwbnky | $15.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Wjsgxrjfpy | Hpmsyl | $12.7 Bil | |
INCY
| Incyte Corp | Yxkhwlj | Gjhxkzp | $12.0 Bil |